300804 广康生化
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)0.2423.0272.6593.17717.221
总资产报酬率 ROA (%)0.1491.9371.8172.17411.335
投入资产回报率 ROIC (%)0.1722.2462.0292.36112.839

边际利润分析
销售毛利率 (%)21.02824.14420.75624.03029.281
营业利润率 (%)0.7376.2564.0756.28616.105
息税前利润/营业总收入 (%)3.1908.0736.2047.75215.753
净利润/营业总收入 (%)1.1015.3554.7336.07514.574

收益指标分析
经营活动净收益/利润总额(%)295.79398.03064.68795.130103.847
价值变动净收益/利润总额(%)156.55415.63328.00313.2710.000
营业外收支净额/利润总额(%)-153.590-10.89014.690-1.657-2.663

偿债能力分析
流动比率 (X)1.6591.7102.0392.0401.282
速动比率 (X)1.2131.3631.7531.7210.890
资产负债率 (%)38.61438.29833.32929.78935.101
带息债务/全部投入资本 (%)27.73927.47020.75324.14924.911
股东权益/带息债务 (%)255.688259.166373.771310.606292.624
股东权益/负债合计 (%)158.725161.016199.875235.690184.890
利息保障倍数 (X)1.1003.3214.3484.943239.800

营运能力分析
应收账款周转天数 (天)92.15084.93281.727100.65161.728
存货周转天数 (天)143.029116.39595.970118.40381.800